Literature DB >> 9697994

Induction of thyroiditis in mice with thyrotropin receptor lacking serologically dominant regions.

S H Wang1, G Carayanniotis, Y Zhang, M Gupta, A M McGregor, J P Banga.   

Abstract

Grave's disease (GD) is characterized by pathogenic autoantibodies to the human thyrotropin receptor (hTSH-R), and is frequently associated with a lymphocytic infiltrate of the thyroid gland. In attempts to establish a murine model of GD, we and others have previously shown that immunization of mice with recombinant preparations of the hTSH-R ectodomain induces high titres of specific antibodies, which, however, are not pathogenic, nor is the response accompanied by the development of thyroiditis. Since earlier reports identified the serological immunodominant determinants within the N- and C-terminal regions of hTSH-R ectodomain, we reasoned that immunization of mice with truncated fragments of ectodomain lacking these dominant regions might result in skewing of the response to other determinants of the molecule, with consequent induction of immunopathological features present in GD. We show here that multiple challenge of BALB/c mice with an amino acid fragment of residues 43-282 generates antibodies directed at hTSH-R peptides 37-56, 157-176, 217-236 and 232-251. This reactivity pattern is distinct from that induced previously with the whole ectodomain of hTSH-R in BALB/c animals. Thyroid function remained unaffected in these mice, suggesting that pathogenic antibodies were not being induced. Interestingly, some animals developed lymphocytic infiltration of the thyroid gland, clearly indicating the presence of pathogenic T cell determinants within the 43-282 fragment. Challenge with the related fragment 43-316 produced the same pattern of serological response to the synthetic peptides as fragment 43 282, but was not accompanied by thyroiditis. The results demonstrate: (i) the presence of thyroiditogenic determinants within hTSH-R, and (ii) that these pathogenic determinants are likely to be cryptic, as their effect is exhibited only when the hierarchy of immunodominance within hTSH-R is drastically altered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697994      PMCID: PMC1905011          DOI: 10.1046/j.1365-2249.1998.00627.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

Review 1.  Autoantibodies to the TSH receptor in patients with autoimmune thyroid disease.

Authors:  A M McGregor
Journal:  Clin Endocrinol (Oxf)       Date:  1990-12       Impact factor: 3.478

Review 2.  The thyrotropin receptor 25 years after its discovery: new insight after its molecular cloning.

Authors:  Y Nagayama; B Rapoport
Journal:  Mol Endocrinol       Date:  1992-02

Review 3.  Immunological and molecular characteristics of the thyroid peroxidase autoantigen.

Authors:  J P Banga; P S Barnett; A M McGregor
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

4.  Human immunoglobulin G autoantibodies to the thyrotropin receptor from Epstein-Barr virus-transformed B lymphocytes: characterization by immunoprecipitation with recombinant antigen and biological activity.

Authors:  N G Morgenthaler; M R Kim; J Tremble; G C Huang; W Richter; M Gupta; W A Scherbaum; A M McGregor; J P Banga
Journal:  J Clin Endocrinol Metab       Date:  1996-09       Impact factor: 5.958

5.  Monoclonal antibodies to the human TSH receptor: epitope mapping and binding to the native receptor on the basolateral plasma membrane of thyroid follicular cells.

Authors:  L B Nicholson; H Vlase; P Graves; M Nilsson; J Molne; G C Huang; N G Morgenthaler; T F Davies; A M McGregor; J P Banga
Journal:  J Mol Endocrinol       Date:  1996-04       Impact factor: 5.098

6.  The autoimmune response induced by immunising female mice with recombinant human thyrotropin receptor varies with the genetic background.

Authors:  S Costagliola; M C Many; M Stalmans-Falys; G Vassart; M Ludgate
Journal:  Mol Cell Endocrinol       Date:  1995-12-29       Impact factor: 4.102

7.  Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule.

Authors:  N Shimojo; Y Kohno; K Yamaguchi; S Kikuoka; A Hoshioka; H Niimi; A Hirai; Y Tamura; Y Saito; L D Kohn; K Tahara
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 8.  Autoantibodies to the thyrotropin receptor.

Authors:  B Rees Smith; S M McLachlan; J Furmaniak
Journal:  Endocr Rev       Date:  1988-02       Impact factor: 19.871

9.  Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading.

Authors:  H Vlase; M Nakashima; P N Graves; Y Tomer; J C Morris; T F Davies
Journal:  Endocrinology       Date:  1995-10       Impact factor: 4.736

10.  Thyrotropin receptor-specific antibodies in BALB/cJ mice with experimental hyperthyroxinemia show a restricted binding specificity and belong to the immunoglobulin G1 subclass.

Authors:  N M Wagle; S A Patibandla; J S Dallas; J C Morris; B S Prabhakar
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

View more
  4 in total

1.  Limitations of the semisynthetic library approach for obtaining human monoclonal autoantibodies to the thyrotropin receptor of Graves' disease.

Authors:  J H Van Der Heijden; T W De Bruin; K A Glaudemans; J De Kruif; J P Banga; T Logtenberg
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

2.  Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease.

Authors:  S Costagliola; M C Many; J F Denef; J Pohlenz; S Refetoff; G Vassart
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.

Authors:  K Barrett; E Liakata; P V Rao; P F Watson; A P Weetman; P Lymberi; J P Banga; G Carayanniotis
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

Review 4.  Excessive Cytosolic DNA Fragments as a Potential Trigger of Graves' Disease: An Encrypted Message Sent by Animal Models.

Authors:  Yuqian Luo; Aya Yoshihara; Kenzaburo Oda; Yuko Ishido; Koichi Suzuki
Journal:  Front Endocrinol (Lausanne)       Date:  2016-11-14       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.